ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 11, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for treatment of prostate cancer, today announced that the Company will be presenting at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18, 2024, at 9:10 a.m. ET in New York, NY.
加利福尼亞州南舊金山和不列顛哥倫比亞省溫哥華，2024年9月11日 /PRNewswire/-專注於開發前列腺癌治療新療法的臨床階段製藥公司ESSA Pharma Inc.（「ESSA」 或 「公司」）（納斯達克股票代碼：EPIX）今天宣佈，該公司將在美國東部時間2024年9月18日星期三上午9點10分在紐約舉行的2024年Cantor全球醫療保健會議上發表演講，紐約。
David R. Parkinson, President and Chief Executive Officer, Peter Virsik, Chief Operating Officer and Executive Vice President, and David S. Wood, Chief Financial Officer, will participate in a fireside chat.
總裁兼首席執行官大衛·帕金森、首席運營官兼執行副總裁彼得·維爾西克和首席財務官戴維·伍德將參加爐邊談話。
A live webcast of the fireside chat can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days.
可以在ESSA網站的 「投資者/活動與演示」 部分觀看爐邊談話的網絡直播，網址爲。活動結束後，網絡直播將在ESSA網站上存檔90天。
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on X and LinkedIn.
關於 ESSA Pharma Inc
ESSA是一家臨床階段的製藥公司，專注於開發用於治療前列腺癌患者的新型專有療法。欲了解更多信息，請訪問並在 X 和 LinkedIn 上關注我們。
Contacts
ESSA Pharma Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]
聯繫人
ESSA 製藥公司
彼得·維爾西克，首席運營官
778.331.0962
[電子郵件保護]
Investors and Media:
Argot Partners
212.600.1902
[email protected]
投資者和媒體：
Argot Par
212.600.1902
[電子郵件保護]
SOURCE ESSA Pharma Inc
來源 ESSA Pharma